This year’s firm rankings cover several practice areas, including copyright, intellectual property transactions, patent litigation, and trademark protection
Sources say the ruling may indicate KIPO’s shifting attitude towards protecting artists’ rights, but appellate bodies are likely to side with agencies
Sources say that the exam format should be revamped to test aptitude rather than rote learning and increase accessibility
The UK government wants to stop local tech going to China, but tech transfer offices often have few options
The executive vice president of partnerships and acquisitions at the NPE explains how his company’s deal with Intel came to be
Counsel at IBM, Novartis, BMS and four other companies delve into whether the new Section 101 bill addresses their concerns
Clearance searches are especially important when counsel can’t rely on the USPTO’s opinion before key deadlines, say sources
Lawyers for Craig Wright will seek approval for expert evidence to help the England and Wales High Court understand how autism affects his character
IP counsel say rude judges can dent their confidence but that the effect on clients should not be underestimated
VLSI case halted in Delaware; Netflix sues Bridgerton rip-off; Ex-GSK scientist escapes damages; US Copyright Office debuts new software; Abbvie scores Humira patent thicket win; Russia tables bill on illegal blocking of copyrighted content
USPTO announces new inclusion initiatives; CBA sues Bilibili for $60m; Japan and Germany dominate future innovators list; Sony flags own website; Interpol nets $11m of fake drugs; Apple avoids earphone infringement trial
Hubertus Schacht of the Munich Regional Court shares his thoughts on German SEP trends and their influence on the UPC
An England and Wales High Court judgment over a disclosure error shows why law firms must never play a distant role when advising clients
Italy is in pole position to replace London as a central division host but must weather a political storm first
The senator’s proposed Section 101 legislation would cut down on exceptions to patent eligibility in the US
Trademark counsel applaud the EUIPO’s new filing system but say it comes with teething issues
South Korean lawyers welcome the trademark guidelines but say the appellate board, courts, and other IP offices may not necessarily agree with the KIPO
Sources say the Supreme Court’s decision to take on Sky v SkyKick puts uncertainty back into the mix, just when IP owners thought they knew what was what
Charles Feng, partner at East & Concord in Beijing, explains why filing for a trademark early is still a brand’s best bet
Jurisdictions
Exclusives and This week in IP
Exclusives and This week in IP
-
The news leaves Milan as the frontrunner for the Unified Patent Court central seat, with diplomatic talks ongoing
-
Sources close to the court, as well as one hopeful applicant, told Managing IP that official offers have yet to be sent
CAS
Sponsored by
CAS
CAS explains the five high-risk areas of IP for R&D organisations and identifies how companies can protect their innovations and safeguard their growth potential
Sponsored by
CAS
CAS shares how patent offices around the world are adopting AI, and explains the benefits of clean data, multiple algorithms, and leveraging human expertise alongside technology
Sponsored by
CAS
The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation
Sponsored by
CAS
Peter Blasi, business development manager at CAS IP Search, explains how to set standards for an effective IP search
Features and Special Focus
Features and Special Focus
Sponsored
Sponsored
-
Sponsored by Gün and PartnersSelin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should be focused on R&D
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property analyses a decision by the China National Intellectual Property Administration on the validity of a pulmonary hypertension drug and the implications for pharmaceutical patentees
-
Sponsored by Purplevine IPXiaoyan Zhou of Purplevine IP explains how the introduction of administrative measures for registering, and filing records relating to, medical devices in China should affect companies’ IP strategy